Disease relevance of Urologic Diseases

• Moderately serious urologic diseases were found in 16.7% of AMs and 9.2% of controls (p = 0.006); significant differences were found only for renal calculi and various causes of increased serum creatinine [1].
• Serum levels of bFGF were measured by ELISA in 39 healthy volunteers, in 37 patients with benign urologic diseases and in 74 RCC patients, 26 of whom revealed lymph node or distant metastases. bFGF expression as detected by IHC was investigated in 777 tissue cores from 259 different RCC patients [median follow-up: 138 (36-240) months] [2].
• Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism [3].
• Among total requests for PSA, 3% were linked to prostate cancer, 18% to a urological disease or symptom and 79% were not linked to any urological condition (opportunistic screening) [4].
• Forty-nine percent were white, 42% black; 21% were Hispanic. Congenital/urologic disease and focal and segmental sclerosis were the leading causes of end-stage renal disease [5].

Psychiatry related information on Urologic Diseases

• Detrusor hyperreflexia is described in patients with neurological disorders, bladder outflow obstruction, persistent enuresis and in female incontinent patients with obvious neurological or urological disease [6].

High impact information on Urologic Diseases

• Statistically significant associations were found with phenacetin-containing analgesics, urological disease and increasing consumption of milk [7].
• No substantial difference in the occurrence of LUTS, UTI or high bladder capacity after Tx was found between children with an underlying urological disease and those with an underlying nephrological disease [8].
• All studies were rated according to the International Consultation on Urological Diseases modification of Oxford Center for Evidence-Based Medicine levels of evidence [9].
• Phosphoinositide signaling in urological disease [10].
• Potential risk factors associated with progressive renal damage in childhood urological diseases: the role of angiotensin-converting enzyme gene polymorphism [11].

Chemical compound and disease context of Urologic Diseases

• MATERIALS AND METHODS: Two boys and 5 girls (mean age 10.9 years) with giggle incontinence, a positive family history of giggle incontinence (4 patients) and no evidence of urological disease were treated with methylphenidate for 1 to 5 years [12].
• 3. Analysis of logarithmic transformed values (ng/mg creatinine) showed that patients with both neoplastic and non-neoplastic urological diseases had significantly higher ferritin levels than normal control subjects (P = 0.02) [13].
• METHODS: From a large data basis, we found retrospectively only 29 children (10 below and 19 above two years of age at first examination) having had at least two Tc-99m mertiatide (Tc-99m MAG3) renographic explorations for various urological diseases, with a decrease of split function of at least 5% between the two examinations [14].
• The urinary activities of alpha-naphthyl acetate esterases were measured for groups of bilharzial and nonbilharzial patients with benign urologic diseases and for others with bladder cancer [15].
• Endoscopic management of urologic disease with the holmium laser [16].

Gene context of Urologic Diseases

• Urinary EGF values were lower in patients with urological diseases of different etiologies than in normal controls (P < 0.005) [17].
• Urinary carcinoembryonic antigen values have been determined in large numbers of specimens from patients with a variety of urologic diseases but most studies have recorded only single measurements at the time of diagnosis [18].
• Specificity of AuraTek FDP was 96% for healthy subjects, 86% in patients with urological disease other than bladder cancer and 80% for patients under surveillance for bladder cancer but with a negative cystoscopic finding at the time of assay [19].
• For each patient, the TMA slides contained a tissue core from the primary tumour, its invasion front and the normal renal parenchyma. bFGF serum levels were higher in RCC patients vs healthy volunteers (P<0.01) and vs patients with benign urologic diseases (P<0.01) [2].
• More information is needed regarding CK20 expression in nonmalignant urological disease, to evaluate its use for routine screening purposes [20].

Analytical, diagnostic and therapeutic context of Urologic Diseases

• Diagnostic tests and tools in the evaluation of urologic disease: Part II [21].

References